Prenetics Global (PRE) FCF Margin (2025 - 2026)
Prenetics Global (PRE) posted quarterly FCF Margin of 37.21% for Q1 2026, up 1227.0% year-over-year from 2.8% in Q1 2025, and up 32.27% quarter-over-quarter from 54.94% in Q4 2025.
Prenetics Global (PRE) FCF Margin (2025 - 2026) Analysis & Trends
Prenetics Global (PRE) has reported FCF Margin for 2 consecutive years, with 37.21% the latest figure, recorded in Q1 2026.
- In Q1 2026, FCF Margin rose 1227.0% year-over-year to 37.21%; the TTM figure through Mar 2026 stood at 33.41% (down 1040.0% YoY), while the FY2025 annual figure was 45.27%, up 14223.0% from the prior year.
- FCF Margin improved to 37.21% in Q1 2026 per PRE's latest filing, from 54.94% in the prior quarter.
- Across five years, FCF Margin topped out at 29.62% in Q2 2025 and bottomed at 54.94% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 13.97% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 20.19% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 26.51% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 10.95% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 8.24% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 2.59% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 13.89% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 27.51% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Prenetics Global | 306.55 Mn | 200.52 Mn | 23.28 Mn | -33.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.21% |
| Dec 31, 2025 | -54.94% |
| Jun 30, 2025 | -29.62% |
| Mar 31, 2025 | -49.49% |